CI
LLY icon

Clal Insurance’s Eli Lilly LLY Stock Holding History

Clal Insurance’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Buy
88,546
+495
+0.6% +$506K 0.48% 48
2026
Q1 		$81M Sell
88,051
-9,994
-10% -$10.1M 0.49% 45
2025
Q4 		$105M Sell
98,045
-39,034
-28% -$37.3M 0.68% 35
2025
Q3 		$105M Buy
137,079
+50,509
+58% +$37.6M 0.8% 34
2025
Q2 		$67.5M Buy
86,570
+515
+0.6% +$400K 0.66% 39
2025
Q1 		$71.1M Sell
86,055
-3,649
-4% -$3.04M 0.73% 35
2024
Q4 		$69.3M Buy
89,704
+4,904
+6% +$4.06M 0.62% 36
2024
Q3 		$75.1M Buy
84,800
+13,200
+18% +$11.9M 0.66% 39
2024
Q2 		$64.8M Sell
71,600
-1,700
-2% -$1.36M 0.68% 36
2024
Q1 		$57M Sell
73,300
-1,200
-2% -$854K 0.64% 40
2023
Q4 		$43.4M Buy
74,500
+73,500
+7,350% +$42.9M 0.57% 47
2023
Q3 		$537K Sell
1,000
-1,000
-50% -$515K 0.01% 105
2023
Q2 		$938K Sell
2,000
-500
-20% -$210K 0.01% 111
2023
Q1 		$859K Buy
+2,500
New +$843K 0.01% 117

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clal Insurance's LLY Position: Q2 2026 in Review

Clal Insurance increased its Eli Lilly (LLY) stake by 0.56% in Q2 2026, buying an estimated $506K and bringing the position to 88,546 shares worth $106M. The position accounts for 0.48% of the portfolio, ranked #48.

Clal Insurance first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clal Insurance held 88,546 shares of Eli Lilly worth $106M as of Q2 2026.
  • Clal Insurance bought 495 Eli Lilly shares in Q2 2026, an estimated $506K.
  • Eli Lilly made up 0.48% of Clal Insurance's portfolio in Q2 2026, its #48 holding.
  • Clal Insurance first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.